Integrated molecular analysis of adult T cell leukemia/lymphoma

[1]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[2]  T. Taki,et al.  Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan , 2016, Pediatric blood & cancer.

[3]  Mihai Albu,et al.  C2H2 zinc finger proteins greatly expand the human regulatory lexicon , 2015, Nature Biotechnology.

[4]  Emily Kang,et al.  Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor , 2015, Cell.

[5]  G. Hummer,et al.  Crystal Structure and Allosteric Activation of Protein Kinase C βII , 2015, Cell.

[6]  L. Staudt,et al.  Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma , 2014, The Journal of experimental medicine.

[7]  S. Behjati,et al.  Dysfunction of phospholipase Cγ in immune disorders and cancer. , 2014, Trends in biochemical sciences.

[8]  K. Ishitsuka,et al.  Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. , 2014, The Lancet. Oncology.

[9]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[10]  J. Valcárcel,et al.  Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers , 2014, Cell.

[11]  I. Lossos,et al.  Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas , 2014, Nature Genetics.

[12]  M. Matsuoka,et al.  Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NFκB activation in adult T-cell leukemia/lymphoma cells , 2014, Leukemia.

[13]  A. Bhatia,et al.  Cellular and molecular mechanisms in cancer immune escape: a comprehensive review , 2014, Expert review of clinical immunology.

[14]  C Haferlach,et al.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes , 2013, Leukemia.

[15]  John K Wiencke,et al.  Quantitative reconstruction of leukocyte subsets using DNA methylation , 2013, Genome Biology.

[16]  S. Ogawa,et al.  Adult T‐cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growth , 2013, Cancer science.

[17]  H. Aburatani,et al.  Integrated molecular analysis of clear-cell renal cell carcinoma , 2013, Nature Genetics.

[18]  S. Paul,et al.  A new look at T cell receptor signaling to nuclear factor-κB. , 2013, Trends in immunology.

[19]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[20]  A. López-Guillermo,et al.  POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia , 2013, Nature Genetics.

[21]  Lieping Chen,et al.  Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.

[22]  H. Kume,et al.  An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data , 2013, Nucleic acids research.

[23]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[24]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[25]  Toshiki Watanabe,et al.  Molecular Hallmarks of Adult T Cell Leukemia , 2012, Front. Microbio..

[26]  Minoru Yoshida,et al.  Splicing in oncogenesis and tumor suppression , 2012, Cancer science.

[27]  Peter A. Jones,et al.  Cancer genetics and epigenetics: two sides of the same coin? , 2012, Cancer cell.

[28]  C. Feschotte,et al.  Endogenous viruses: insights into viral evolution and impact on host biology , 2012, Nature Reviews Genetics.

[29]  L. Staudt,et al.  Pathogenesis of human B cell lymphomas. , 2012, Annual review of immunology.

[30]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[31]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[32]  S. Ghosh,et al.  Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.

[33]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[34]  M. J. Mallory,et al.  Signal- and Development-Dependent Alternative Splicing of LEF1 in T Cells Is Controlled by CELF2 , 2011, Molecular and Cellular Biology.

[35]  R. Aqeilan,et al.  The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis. , 2011, Blood.

[36]  S. M. Burden-Gulley,et al.  Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration , 2011, Journal of cellular biochemistry.

[37]  HongxingGui XinTong.  Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway , 2011 .

[38]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[39]  S. Hailfinger,et al.  Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. , 2010, Cold Spring Harbor perspectives in biology.

[40]  K. Yamaguchi,et al.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.

[41]  A. Ferrando,et al.  Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia , 2010, Nature Immunology.

[42]  B. Binder,et al.  Crosstalk between the NF-κB activating IKK-complex and the CSN signalosome , 2009, Journal of cellular and molecular medicine.

[43]  K. Tsukasaki.  [Treatment for adult T-cell leukemia-lymphoma]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[44]  H. Schneider,et al.  CD28 and CTLA‐4 coreceptor expression and signal transduction , 2009, Immunological reviews.

[45]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[46]  Jun Zhang,et al.  Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival , 2009, Nature.

[47]  M. Boxus,et al.  The HTLV-1 Tax interactome , 2008, Retrovirology.

[48]  W. Greene,et al.  The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. , 2008, Annual review of immunology.

[49]  Motohiro Kato,et al.  Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.

[50]  H. Mackay,et al.  Targeting the protein kinase C family: are we there yet? , 2007, Nature Reviews Cancer.

[51]  Kuan-Teh Jeang,et al.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.

[52]  J. Bates,et al.  Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. , 2007, Blood.

[53]  David J. Rawlings,et al.  Phosphorylation of the CARMA1 Linker Controls NF-κB Activation , 2005 .

[54]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Mitsuhiro Osame,et al.  Cellular immune response to HTLV-1 , 2005, Oncogene.

[56]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[57]  C. Glass,et al.  A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.

[58]  S. Goodbourn,et al.  Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. , 2003, Nucleic acids research.

[59]  D. Litchfield.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. , 2003, The Biochemical journal.

[60]  G. Melino,et al.  p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.

[61]  X. Bustelo.  Regulatory and Signaling Properties of the Vav Family , 2000, Molecular and Cellular Biology.

[62]  K. A. Wall,et al.  Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.